07:00 , Sep 14, 2009 |  BC Week In Review  |  Company News

Trinity Biosystems management update

Trinity Biosystems Inc. , Menlo Park, Calif.   Business: Drug delivery   Hired: Rene Castro as CBO, formerly CBO of Anza Therapeutics Inc.  ...
08:00 , Nov 13, 2008 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

This week in techniques Approach Summary Licensing status Publication and contact information Drug platforms Attenuated bacterial strains to treat cancer In vitro and mouse studies suggest that attenuated Listeria monocytogenes that express melanoma antigens could...
08:00 , Nov 13, 2008 |  BC Innovations  |  Targets & Mechanisms

MELOE target for melanoma

Despite the identification of an increasing number of melanoma-specific antigens, including MAGE-1, Melan-A and tyrosinase , 1 response rates for melanoma immunotherapy still hover at only 5-10%, 2 due in part to the heterogeneity of...
07:00 , May 19, 2008 |  BioCentury  |  Finance

Ebb & Flow Focus

The American Society of Clinical Oncology meeting is on the horizon, with the first spate of corporate press releases pouring forth last week to coincide with posting of abstracts for the May 30-June 2 conference...
08:00 , Dec 3, 2007 |  BC Week In Review  |  Company News

Cerus cancer, infectious news

CERS spun out its immunotherapy programs into newco Anza Therapeutics Inc. , located in Concord, Calif. Anza concurrently received an undisclosed amount of venture financing from undisclosed investors. Anza's assets include CERS's attenuated Listeria vaccine...